151 related articles for article (PubMed ID: 19598290)
1. Synthesis and characterization of new liver targeting 5-fluorouracil-cholic acid conjugates.
Qian S; Wu JB; Wu XC; Li J; Wu Y
Arch Pharm (Weinheim); 2009 Sep; 342(9):513-20. PubMed ID: 19598290
[TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of N(3)-O-toluyl-fluorouracil-loaded liposomes.
Sun W; Zhang N; Li A; Zou W; Xu W
Int J Pharm; 2008 Apr; 353(1-2):243-50. PubMed ID: 18155370
[TBL] [Abstract][Full Text] [Related]
3. Selective bone targeting 5-fluorouracil prodrugs: synthesis and preliminary biological evaluation.
Ouyang L; He D; Zhang J; He G; Jiang B; Wang Q; Chen Z; Pan J; Li Y; Guo L
Bioorg Med Chem; 2011 Jun; 19(12):3750-6. PubMed ID: 21612935
[TBL] [Abstract][Full Text] [Related]
4. Organ distribution of 5-fluorouracil loaded gelatine microspheres in mice.
Hao X; Cheng G; Zou M; Sun J; Cui F
Pharmazie; 2004 Sep; 59(9):709-12. PubMed ID: 15497754
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and properties of N-nicotinoyl-2-(5-fluorouracil-1-yl)-D,L-glycine ester as a prodrug of 5-fluorouracil for rectal administration.
Yang YW; Lee JS; Kim I; Jung YJ; Kim YM
Eur J Pharm Biopharm; 2007 May; 66(2):260-7. PubMed ID: 17182232
[TBL] [Abstract][Full Text] [Related]
6. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice.
Singh P; Gupta U; Asthana A; Jain NK
Bioconjug Chem; 2008 Nov; 19(11):2239-52. PubMed ID: 18950215
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and tissue distribution of 5-fluorouracil encapsulated by galactosylceramide liposomes in mice.
Jin Y; Li J; Rong LF; Lü XW; Huang Y; Xu SY
Acta Pharmacol Sin; 2005 Feb; 26(2):250-6. PubMed ID: 15663907
[TBL] [Abstract][Full Text] [Related]
8. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study.
Chandrashekar NS; Shobha Rani RH
J BUON; 2007; 12(4):529-34. PubMed ID: 18067212
[TBL] [Abstract][Full Text] [Related]
9. Nanoassemblies containing a fluorouracil/zidovudine glyceryl prodrug with phospholipase A2-triggered drug release for cancer treatment.
Jin Y; Yang F; Du L
Colloids Surf B Biointerfaces; 2013 Dec; 112():421-8. PubMed ID: 24036626
[TBL] [Abstract][Full Text] [Related]
10. Novel thermosensitive 5-fluorouracil-cyclotriphosphazene conjugates: synthesis, thermosensitivity, degradability, and in vitro antitumor activity.
Cho YW; Lee JR; Song SC
Bioconjug Chem; 2005; 16(6):1529-35. PubMed ID: 16287251
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of dendrimer prodrugs for oral drug delivery.
Najlah M; Freeman S; Attwood D; D'Emanuele A
Int J Pharm; 2007 May; 336(1):183-90. PubMed ID: 17188439
[TBL] [Abstract][Full Text] [Related]
12. Preparation and Bioactivity Assessment of Chitosan-1-Acetic Acid-5-Flurouracil Conjugates as Cancer Prodrugs.
Mohammed MO; Hussain KS; Haj NQ
Molecules; 2017 Nov; 22(11):. PubMed ID: 29117097
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and in vitro drug release investigation of new potential 5-FU prodrugs.
Daumar P; Decombat C; Chezal JM; Debiton E; Madesclaire M; Coudert P; Galmier MJ
Eur J Med Chem; 2011 Jul; 46(7):2867-79. PubMed ID: 21530016
[TBL] [Abstract][Full Text] [Related]
14. [Synthesis of prodrugs of tacrine hydrochloride and evaluation of the stability and biodistribution in mice].
Jiang Y; Zhang Y; Zhang ZR
Yao Xue Xue Bao; 2003 Dec; 38(12):962-5. PubMed ID: 15040096
[TBL] [Abstract][Full Text] [Related]
15. Novel liver-specific cholic acid-cytarabine conjugates with potent antitumor activities: Synthesis and biological characterization.
Chen DQ; Wang X; Chen L; He JX; Miao ZH; Shen JK
Acta Pharmacol Sin; 2011 May; 32(5):664-72. PubMed ID: 21516131
[TBL] [Abstract][Full Text] [Related]
16. Topical delivery of 5-fluorouracil (5-FU) by 3-alkylcarbonyloxymethyl-5-FU prodrugs.
Roberts WJ; Sloan KB
J Pharm Sci; 2003 May; 92(5):1028-36. PubMed ID: 12712422
[TBL] [Abstract][Full Text] [Related]
17. The role of pro-drug therapy in the treatment of cancer.
Ferguson MJ; Ahmed FY; Cassidy J
Drug Resist Updat; 2001 Aug; 4(4):225-32. PubMed ID: 11991677
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and photochemical properties of photoactivated antitumor prodrugs releasing 5-fluorouracil.
Zhang Z; Hatta H; Ito T; Nishimoto S
Org Biomol Chem; 2005 Feb; 3(4):592-6. PubMed ID: 15703793
[TBL] [Abstract][Full Text] [Related]
19. [Tissue distribution and excretion of 5-fluorouracil from indomethacin 5-fluorouracil-1-ylmethylester in rats].
Wang GH; Wang J; Qi W; Chen Y; Sun LX
Yao Xue Xue Bao; 2008 Jan; 43(1):81-5. PubMed ID: 18357738
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics and distribution of 5-Fu magnetic albumin deuto-microsphere in normal and tumor-bearing mice].
Xu R; Shi SJ; Zhou SC; Zheng JW; Chen H; Zou SQ; Zeng FD
Yao Xue Xue Bao; 2007 Jan; 42(1):66-70. PubMed ID: 17520810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
